Please assess the completion status of the following clinical trial:

Trial Title: Study of the Safety and Efficacy of Botox in Bruxism

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 1. Patients between the ages of 18 and 80 years old with a diagnosis of bruxism, based on the standard criteria.~* 2. If the subject is a female of childbearing age, she must have had a hysterectomy, tubal ligation, or otherwise be incapable of pregnancy, or have practiced a method of contraception (hormonal contraceptives, spermicidal barrier, intrauterine device, partner sterility) at least one month prior to study entry. Any female of childbearing age will have a urine pregnancy test one week prior to the treatment (visit 2).~* 3. Ability of the patient or guardian to sign and understand informed consent.~* 4. Ability to follow and comply with study directions.~Exclusion Criteria:~* 1. Coexistence of active psychosis, other active psychiatric disease or cognitive impairment.~* 2. Coexistence of serious co-morbid conditions.~* 3. Exposure to any botulinum toxin preparation within the past 6 months.~* 4. Participation in another experimental therapeutic protocol within 30 days.~* 5. Any medical condition in which the administration of botulinum toxin is contraindicated, including myasthenia gravis, amyotrophic lateral sclerosis or other neuromuscular diseases.~* 6. History of dysphagia.~* 7. History of botulism.~* 8. A condition or situation in which the investigators view will confound the ability of the subject to participate in the study.~* 9. Patients or guardian who are unable to understand and sign informed consent.~* 10. Pregnancy~* 11. Patients who do not meet inclusion criteria.~* 12. Patients in whom it is felt that a major portion of overall sleep morbidity is not related to bruxism.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): Placebo arm
- botulinum toxin type A (Type: ACTIVE_COMPARATOR): Active arm

Based on this trial design, predict the completion outcome and termination type (if applicable).